Email ID
Password
Sign me in automatically next time
First filing for Astellas' SGLT2 inhibitor contender ipragliflozin, in Japan

Astellas has landed the first blow in what will be a highly competitive market for sodium-glucose co-transporter 2 (SGLT2) inhibitors in Japan, with an approval filing for ipragliflozin (ASP1941) for...
14 March 2013
Ian Haydock

ian.haydock@informa.com





Please Login to read the full article.
EVENTS
04 April 2016
Stockholm, Sweden
06 April 2016
Hamburg, Germany
JOB OF THE WEEK Promote your job vacancy
© 2016 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36